TARSUS PHARMACEUTICALS INC
TARSUS PHARMACEUTICALS INC logo
TARS

TARSUS PHARMACEUTICALS INC (TARS)

$16.260.06%

Market is closed
– opens on 8 PM, 06 Feb 2023
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$16.04
Day's Range
$16.465
$10.8
52-Week Range
$20.82
1 month return11.75%
3 month return8.29%
1 year return4.91%
5 year return20.99%

Analyst Recommendation

based on 14 analysts ratings

Buy
92%
Buy
7%
Hold
0%
Sell

Based on 14 Wall street analysts offering stock ratings for TARSUS PHARMACEUTICALS INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 199.57%

Current

$16.26

Target

$48.71

Recommendation Trend

Based on 14 analyst

Current1M Ago3M Ago
Buy
13
13
13
Hold
1
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization430.5M
Book Value$7.6
Dividend Share0.0
Dividend Yield0.0%
Earnings Per Share (EPS)-2.15
Wall Street Target Price48.71

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)2.04
Enterprise Value206.4M
Enterprise Value/Revenue12.78
Enterprise Value/Ebitda-3.45

Technicals

Beta0.67
50 Day MA15.42
200 Day MA15.63

Institutional Holdings

Vivo Capital, LLC

8.48%

TANG CAPITAL MANAGEMENT LLC

7.84%

RTW INVESTMENTS, LLC

7.59%

Cormorant Asset Management, LLC

7.39%

TimesSquare Capital Management, LLC

5.7%

Deerfield Management Co

4.96%

Company Information

Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care. It is advancing its pipeline to address a number of diseases with high unmet need across a range of therapeutic categories, including eye care, dermatology, and infectious disease prevention. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 for the treatment of Demodex blepharitis. TP-03 is also being developed for the treatment of Meibomian Gland Disease.
OrganizationTARSUS PHARMACEUTICALS INC
Employees46
CEODr. Bobak R. Azamian M.D.
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is TARSUS PHARMACEUTICALS INC share price today?

Can Indians buy TARSUS PHARMACEUTICALS INC shares?

How can I buy TARSUS PHARMACEUTICALS INC shares from India?

Can Fractional shares of TARSUS PHARMACEUTICALS INC be purchased?

What are the documents required to start investing in TARSUS PHARMACEUTICALS INC stocks?

What are today’s High and Low prices of TARSUS PHARMACEUTICALS INC?

What are today’s traded volumes of TARSUS PHARMACEUTICALS INC?

What is today’s market capitalisation of TARSUS PHARMACEUTICALS INC?

What is the 52 Week High and Low Range of TARSUS PHARMACEUTICALS INC?

How much percentage TARSUS PHARMACEUTICALS INC is down from its 52 Week High?

How much percentage TARSUS PHARMACEUTICALS INC is up from its 52 Week low?

What are the historical returns of TARSUS PHARMACEUTICALS INC?

Who is the Chief Executive Officer (CEO) of TARSUS PHARMACEUTICALS INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*